Janssen Takes Further Legal Action to Help End the Distribution of Counterfeit HIV Medicines in the United States
September 02, 2023
September 02, 2023
CHICAGO, Illinois, Sept. 2 -- The Janssen Pharmaceutical Companies of Johnson and Johnson issued the following news release:
The Janssen Pharmaceutical Companies of Johnson & Johnson (the Company) confirms it has taken further legal action to help end the distribution of counterfeit medicines for the treatment of human immunodeficiency virus (HIV) in the United States following an investigation that identified criminal activity involving distributors not authorized to sell Janss . . .
The Janssen Pharmaceutical Companies of Johnson & Johnson (the Company) confirms it has taken further legal action to help end the distribution of counterfeit medicines for the treatment of human immunodeficiency virus (HIV) in the United States following an investigation that identified criminal activity involving distributors not authorized to sell Janss . . .